Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
Condition: Plaque Psoriasis Interventions: Biological: secukinumab; Drug: Methotrexate; Drug: Cyclosporin A; Drug: Acitretin Sponsors: Singapore General Hospital; Translational Immunology Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials